Literature DB >> 6651277

Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics.

M S Stone, R J Wallace, J M Swenson, C Thornsberry, L A Christensen.   

Abstract

An agar disk elution method using round well plates, supplemented Mueller-Hinton agar, and commercial drug disks is described for susceptibility testing of Mycobacterium marinum and the rapidly growing mycobacteria to antibiotics and sulfonamides. By this method, 14 of 14 strains of M. marinum were susceptible to rifampin, doxycycline, minocycline, and trimethoprim-sulfamethoxazole. Identical results were obtained with Middlebrook 7H10 agar and drugs prepared from standard powders. With 58 isolates of Mycobacterium fortuitum and Mycobacterium chelonei, this method had a 92% correlation with broth minimal inhibitory concentration determinations for cefoxitin and greater than 98% for doxycycline, kanamycin, amikacin, and the sulfonamides. Sixty-nine percent of isolates of M. chelonei susceptible to amikacin on supplemented Mueller-Hinton agar were resistant on 7H10 agar, and 15 of 16 M. chelonei isolates susceptible to erythromycin in broth were resistant by disk elution when an endpoint of no growth was used with either agar. The agar disk elution method offers a practical method for testing of most antibacterial agents against these mycobacterial species.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651277      PMCID: PMC185360          DOI: 10.1128/AAC.24.4.486

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

1.  Mycobacterium marinum infection.

Authors:  J Kirk; G W Kaminski
Journal:  Australas J Dermatol       Date:  1976-12       Impact factor: 2.875

2.  Letter: Tetracycline therapy for atypical mycobacterial granuloma.

Authors:  R Kim
Journal:  Arch Dermatol       Date:  1974-08

3.  Sporotrichoid Mycobacterium marinum infection treated with rifampin-ethambutol.

Authors:  E Wolinsky; F Gomez; F Zimpfer
Journal:  Am Rev Respir Dis       Date:  1972-06

4.  Preparation of tuberculosis susceptibility testing mediums by means of impregnated disks.

Authors:  L G Wayne; I Krasnow
Journal:  Am J Clin Pathol       Date:  1966-06       Impact factor: 2.493

5.  Stability of antibiotics and chemotherapeutics in agar plates.

Authors:  K J Ryan; G M Needham; C L Dunsmoor; J C Sherris
Journal:  Appl Microbiol       Date:  1970-09

6.  Cooperative field test of drug-impregnated discs for susceptibility testing of mycobacteria.

Authors:  M E Griffith; M L Matajack; M L Bissett; R M Wood
Journal:  Am Rev Respir Dis       Date:  1971-03

7.  Minocycline hydrochloride treatment for atypical acid-fast infection.

Authors:  P R Loria
Journal:  Arch Dermatol       Date:  1976-04

8.  The successful treatment of tropical fish tank granuloma (Mycobacterium marinum) with co-trimoxazole.

Authors:  M M Black; S J Eykyn
Journal:  Br J Dermatol       Date:  1977-12       Impact factor: 9.302

9.  In vitro sensitivity of Mycobacterium marinum to minocycline and doxycycline.

Authors:  J R Torres; M Sands; C V Sanders
Journal:  Tubercle       Date:  1978-09

10.  In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.

Authors:  J R Dalovisio; G A Pankey
Journal:  J Infect Dis       Date:  1978-03       Impact factor: 5.226

View more
  15 in total

1.  Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.

Authors:  B Phetsuksiri; A R Baulard; A M Cooper; D E Minnikin; J D Douglas; G S Besra; P J Brennan
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

3.  Isolation of Mycobacterium thermoresistibile following augmentation mammaplasty.

Authors:  J M Wolfe; D F Moore
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

4.  Evaluation of Etest for susceptibility testing of rapidly growing mycobacteria.

Authors:  J R Biehle; S J Cavalieri; M A Saubolle; L J Getsinger
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

5.  Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum.

Authors:  S E Hoffner; L Klintz; B Olsson-Liljequist; A Bolmström
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

6.  Application of the Etest to the antimicrobial susceptibility testing of Mycobacterium marinum clinical isolates.

Authors:  C M Flynn; C M Kelley; M S Barrett; R N Jones
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

7.  Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.

Authors:  R A Slayden; R E Lee; J W Armour; A M Cooper; I M Orme; P J Brennan; G S Besra
Journal:  Antimicrob Agents Chemother       Date:  1996-12       Impact factor: 5.191

8.  Antibiotic susceptibility pattern of Mycobacterium marinum.

Authors:  A Aubry; V Jarlier; S Escolano; C Truffot-Pernot; E Cambau
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

9.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.

Authors:  J M Swenson; R J Wallace; V A Silcox; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

Review 10.  Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria.

Authors:  Barbara A Brown-Elliott; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.